Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Illinois Cancer Specialists
mi
from
Arlington Heights, IL
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Illinois Cancer Specialists
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Illinois Cancer Specialists
mi
from
Niles, IL
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Illinois Cancer Specialists
mi
from
Niles, IL
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Indiana University Health Central Indiana Cancer Centers
mi
from
Carmel, IN
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Indiana University Health Central Indiana Cancer Centers
mi
from
Carmel, IN
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Indiana University Health Central Indiana Cancer Centers
mi
from
Fishers, IN
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Indiana University Health Central Indiana Cancer Centers
mi
from
Fishers, IN
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Indiana University Health Central Indiana Cancer Centers
mi
from
Greenfield, IN
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Indiana University Health Central Indiana Cancer Centers
mi
from
Greenfield, IN
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Indiana University Health Central Indiana Cancer Centers
mi
from
Indianapolis, IN
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Indiana University Health Central Indiana Cancer Centers
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Missouri Cancer Associates
mi
from
Columbia, MO
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Missouri Cancer Associates
mi
from
Columbia, MO
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Nebraska Methodist Hospital
mi
from
Omaha, NE
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Nebraska Methodist Hospital
mi
from
Omaha, NE
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Comprehensive Cancer Centers of Nevada
mi
from
Henderson, NV
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada
mi
from
Henderson, NV
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
US Oncology West Region
mi
from
Henderson, NV
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
US Oncology West Region
mi
from
Henderson, NV
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Hematology Oncology Associates of Northern NJ
mi
from
Morristown, NJ
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Hematology Oncology Associates of Northern NJ
mi
from
Morristown, NJ
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Hematology-Oncology Associates of Northern NJ, PA
mi
from
Parsippany, NJ
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Hematology-Oncology Associates of Northern NJ, PA
mi
from
Parsippany, NJ
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
New York Oncology Hematology PC
mi
from
Albany, NY
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
New York Oncology Hematology PC
mi
from
Albany, NY
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
New York Oncology, Hematology
mi
from
Latham, NY
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
New York Oncology, Hematology
mi
from
Latham, NY
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
New York Oncology Hematology, PC
mi
from
Rexford, NY
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
New York Oncology Hematology, PC
mi
from
Rexford, NY
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
New York Oncology Hematology, Pc
mi
from
Troy, NY
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
New York Oncology Hematology, Pc
mi
from
Troy, NY
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Raleigh Hematology Oncology Associates
mi
from
Cary, NC
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Raleigh Hematology Oncology Associates
mi
from
Cary, NC
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Raleigh Hematology Oncology Associates
mi
from
Raleigh, NC
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Raleigh Hematology Oncology Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Northwest Cancer Specialists, Pc
mi
from
Portland, OR
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Northwest Cancer Specialists, Pc
mi
from
Portland, OR
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Northwest Cancer Specialists, PC
mi
from
Tualatin, OR
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Northwest Cancer Specialists, PC
mi
from
Tualatin, OR
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Penn State Milton S. Hershey Medical Center, Penn State Cancer Institute
mi
from
Hershey, PA
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Penn State Milton S. Hershey Medical Center, Penn State Cancer Institute
mi
from
Hershey, PA
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina University Hospital
mi
from
Charleston, SC
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina University Hospital
mi
from
Charleston, SC
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology, P.A. -Amarillo
mi
from
Amarillo, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology, P.A. -Amarillo
mi
from
Amarillo, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology-Beaumont, Mamie McFaddin Ward Cancer Center
mi
from
Beaumont, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology-Beaumont, Mamie McFaddin Ward Cancer Center
mi
from
Beaumont, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology, P.A. - Bedford
mi
from
Bedford, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology, P.A. - Bedford
mi
from
Bedford, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology-Baylor Charles A. Sammons Cancer Center
mi
from
Dallas, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology-Baylor Charles A. Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology- Fort Worth - 12th Avenue
mi
from
Fort Worth, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology- Fort Worth - 12th Avenue
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - Southwest Fort Worth
mi
from
Fort Worth, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - Southwest Fort Worth
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Investigational Products Center (IPC)
mi
from
Fort Worth, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Investigational Products Center (IPC)
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Investigational Products Center (lPC)
mi
from
Fort Worth, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Investigational Products Center (lPC)
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
US Oncology Research and Clinical Pharmacy
mi
from
Fort Worth, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
US Oncology Research and Clinical Pharmacy
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - Grapevine
mi
from
Grapevine, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - Grapevine
mi
from
Grapevine, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Cancer Care Centers of South Texas
mi
from
Kerrville, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Cancer Care Centers of South Texas
mi
from
Kerrville, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - McAllen South Second Street
mi
from
McAllen, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - McAllen South Second Street
mi
from
McAllen, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology-Midland Allison Cancer Center
mi
from
Midland, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology-Midland Allison Cancer Center
mi
from
Midland, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Cancer Care Centers of South Texas
mi
from
San Antonio, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Cancer Care Centers of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - Deke Slayton Cancer Center
mi
from
Webster, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - Deke Slayton Cancer Center
mi
from
Webster, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - Weslaco
mi
from
Weslaco, TX
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - Weslaco
mi
from
Weslaco, TX
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care
mi
from
Christiansburg, VA
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care
mi
from
Christiansburg, VA
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Oncology & Hematology Associates of Southwest Virginia, Inc. D.B.A Blue Ridge Cancer Care
mi
from
Low Moor, VA
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Oncology & Hematology Associates of Southwest Virginia, Inc. D.B.A Blue Ridge Cancer Care
mi
from
Low Moor, VA
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Oncology and Hematology Associates of Southwest Virginia, Inc., dba Blue Ridge Cancer Care
mi
from
Roanoke, VA
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Oncology and Hematology Associates of Southwest Virginia, Inc., dba Blue Ridge Cancer Care
mi
from
Roanoke, VA
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care
mi
from
Salem, VA
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care
mi
from
Salem, VA
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care
mi
from
Wytheville, VA
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care
mi
from
Wytheville, VA
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Northwest Cancer Specialists
mi
from
Vancouver, WA
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Northwest Cancer Specialists
mi
from
Vancouver, WA
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Wenatchee Valley Medical Center
mi
from
Wenatchee, WA
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Wenatchee Valley Medical Center
mi
from
Wenatchee, WA
Click here to add this to my saved trials
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Clinic of Oncology
mi
from
Banja Luka,
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Ag-013736 (Axitinib) For The Treatment Of Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Clinic of Oncology
mi
from
Banja Luka,
Click here to add this to my saved trials
Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies
Phase I Dose Escalation Study of Accelerated Fractionation With Esophageal Sparing Using Intensity-Modulated Radiation Therapy for Locally-Advanced Thoracic Malignancies Including a Prospective Assessment of Esophageal Motion and Radiation-Induced Esophageal Injury
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies
Phase I Dose Escalation Study of Accelerated Fractionation With Esophageal Sparing Using Intensity-Modulated Radiation Therapy for Locally-Advanced Thoracic Malignancies Including a Prospective Assessment of Esophageal Motion and Radiation-Induced Esophageal Injury
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Study of Anatomic Nerve Sparing Radical Perineal Prostatectomy
Clinical Outcomes for Anatomic Nerve Sparing Radical Perineal Prostatectomy
Status: Enrolling
Updated:  12/31/1969
Maimonides Medical Center
mi
from
Brooklyn, NY
Study of Anatomic Nerve Sparing Radical Perineal Prostatectomy
Clinical Outcomes for Anatomic Nerve Sparing Radical Perineal Prostatectomy
Status: Enrolling
Updated: 12/31/1969
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials